Effect of TLR-4 gene polymorphisms on sepsis susceptibility in neonates: a systematic review and meta-analysis

Biomark Med. 2022 Sep;16(13):1005-1017. doi: 10.2217/bmm-2022-0390. Epub 2022 Sep 2.

Abstract

Aim: To clarify the role of polymorphisms rs4986790 and rs4986791 in TLR-4 with susceptibility to neonatal sepsis. Methods: To evaluate the possible correlation of polymorphisms rs4986790 and rs4986791 with sepsis risk, odds ratios (ORs) were calculated. The heterogeneity was evaluated by χ2-based Q-test. Results: For rs4986790, ORs were 1.36 (95% CI: 1.05-1.79, p = 0.017) and 1.84 (95% CI: 0.04-7.9, p = 0.410) under AG+GG versus AA and G vs A models, respectively. For rs4986791, ORs were 2.22 (95% CI: 1.25-3.94, p = 0.006) and 2.20 (95% CI: 1.26-3.85, p = 0.005) under CT+TT versus CC and of T versus C models, respectively. Conclusion: The rs4986790 and rs4986791 polymorphisms in TLR-4 could influence the sepsis susceptibility in neonates.

Keywords: TLR-4; neonatal; rs4986790; rs4986791; sepsis.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Genetic Predisposition to Disease*
  • Humans
  • Infant, Newborn
  • Odds Ratio
  • Polymorphism, Single Nucleotide
  • Sepsis* / genetics
  • Toll-Like Receptor 4 / genetics*

Substances

  • TLR4 protein, human
  • Toll-Like Receptor 4